Bencivenga, Tammaro Claudio (2011) Role of Twist1 transcription factor in thyroid tumor progression. [Tesi di dottorato] (Inedito)

[img]
Anteprima
PDF
Bencivenga_TC.pdf

Download (13MB) | Anteprima
Tipologia del documento: Tesi di dottorato
Lingua: English
Titolo: Role of Twist1 transcription factor in thyroid tumor progression
Autori:
AutoreEmail
Bencivenga, Tammaro Claudiobencivengaclaudio@tiscali.it
Data: 30 Novembre 2011
Numero di pagine: 125
Istituzione: Università degli Studi di Napoli Federico II
Dipartimento: Biologia e patologia cellullare e molecolare "L. Califano"
Scuola di dottorato: Medicina molecolare
Dottorato: Oncologia ed endocrinologia molecolare
Ciclo di dottorato: 24
Coordinatore del Corso di dottorato:
nomeemail
Santoro, Massimomasantor@unina.it
Tutor:
nomeemail
Salvatore, Giulianagsalvato@unina.it
Data: 30 Novembre 2011
Numero di pagine: 125
Parole chiave: Thyroid carcinoma; Twist1; Apoptosis
Settori scientifico-disciplinari del MIUR: Area 06 - Scienze mediche > MED/04 - Patologia generale
Depositato il: 09 Dic 2011 10:18
Ultima modifica: 30 Apr 2014 19:48
URI: http://www.fedoa.unina.it/id/eprint/8747
DOI: 10.6092/UNINA/FEDOA/8747

Abstract

Thyroid carcinomas are the most common endocrine tumors in humans, with a globally increasing incidence. Differentiated tumors, such as papillary (PTC) and follicular (FTC) thyroid cancers, are often curable with surgical resection and radiotherapy, whereas undifferentiated (anaplastic) thyroid carcinoma (ATC) is invariably lethal, due to the high invasiveness and insensitivity to radioiodine or chemotherapeutic treatment. Little is known about the molecular events that lead from the highly curable differentiated tumors to the very aggressive ATC. Through, a cDNA microarray analysis on different thyroid tumors we have isolated Twist1 as a gene upregulated in ATC. Twist1 is a highly conserved basic helix-loop-helix transcription factor that plays an important role in the development and progression of human cancer. Twist1 has been associated with epithelial-tomesenchymal transition (EMT) a key step during embryonic morphogenesis and in the progression of primary tumors toward metastasis. In this dissertation, we have shown that approximately 50% of ATCs upregulate Twist1 with respect to normal thyroids as well as to poorly- and well-differentiated thyroid carcinomas. Knockdown of Twist1 by RNA interference in ATC cells reduced cell migration and invasion and increased sensitivity to apoptosis. The ectopic expression of Twist1 in thyroid cells induced resistance to apoptosis and increased cell migration and invasion. To understand the molecular mechanisms through which Twist1 exert is biological effects in thyroid cancer cells, we have performed a microarray analysis of thyroid cancer cells ectopically expressing Twist1 in comparison to vector control cells. We have identified a set of 20 genes involved in migration, invasion and apoptosis; expression levels of these genes changed upon Twist1 overexpression or knockdown. Silencing of 5 of the 20 target genes reduced viability of thyroid cancer cells overexpressing Twist1. Thus, our data suggest that Twist1 plays a key role in determining malignant features of the anaplastic phenotype and identifies a set of Twist1 target genes that could be used as molecular target for the therapy of ATC.

Actions (login required)

Modifica documento Modifica documento